<DOC>
	<DOCNO>NCT03028974</DOCNO>
	<brief_summary>The purpose study get well understanding natural adaptive immune response flu virus compare immune cell responses FDA-licensed flu vaccine nasal mucosal cell blood .</brief_summary>
	<brief_title>Innate Acquired Immunity Influenza Infection Immunization ( SLVP029 )</brief_title>
	<detailed_description>This study healthy child adult receive current seasonal influenza vaccine . The volunteer enrol one 7 group 5-year period . Immunization administer ; blood sample NP swab collect various time point base group assign . Group A ( LAIV4/annual return ) : Up six 2-4 year old volunteer give quadrivalent live , attenuate influenza vaccine ( LAIV4 ) . All participant group ask return annually flu immunization blood sample Day 0 Day 7 post immunization . Vaccine naive child return 30 day later second immunization per standard care . This group discontinue year 3 due Advisory Committee Immunization Practices ( ACIP ) recommendation use LAIV . Group B ( LAIV4/ single year ) : Up twenty 2-4 year old volunteer give quadrivalent live , attenuate influenza vaccine ( LAIV4 ) . Volunteers participate single year . All participant group immunize Day 0 . Blood sample take Day 0 Day 7 post immunization . Vaccine naive child return 30 day later second immunization per standard care . This group discontinue year 3 due ACIP recommendation use LAIV . Group C ( LAIV4/NP swab group ) : Up twenty 2-4 year old volunteer give quadrivalent live , attenuate influenza vaccine ( LAIV4 ) . Nasopharyngeal sample ( NP ) swab collect Day 1 21 28 post immunization . No blood collect group . Vaccine naive child return 30 day later second immunization per standard care . This group discontinue year 3 due ACIP recommendation use LAIV . Group D ( IIV4/annual return ) : Up six 6 month-23 month old ( inclusive ) volunteer give quadrivalent inactivated influenza vaccine ( IIV4 ) . All participant group ask return annually flu immunization blood sample Day 0 Day 7 post immunization . Vaccine naive child return 30 day later second immunization per standard care . Group E ( IIV4/single year ) : Up twenty 6 month-23 month old ( inclusive ) volunteer give quadrivalent inactivated influenza vaccine ( IIV4 ) . Volunteers participate single year . All participant group immunize Day 0 . Blood sample take Day 0 Day 7 post immunization . Vaccine naive child return 30 day later second immunization per standard care . Group F ( LAIV4/single year ) Up forty 9-13 year old ( n= 20 ) 18-49 year old ( n= 20 ) volunteer give live , attenuated influenza vaccine ( LAIV ) . Blood sample collect Days 0 , 7 , 28 NP swab collect Days 1 28 . This group discontinue year 3 due ACIP recommendation use LAIV . Group G ( IIV4/single year ) Up forty , 9-13 year old ( n= 20 ) 18-49 year old ( n= 20 ) volunteer give quadrivalent inactivated influenza vaccine ( IIV4 ) . Blood sample collect Day 0,7 , 28</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Otherwise healthy , 6 mo49 yearold volunteer . 2 . Willing complete informed consent process ( include assent minor 717 year age ) . 3 . Availability followup plan duration study . 4 . For parent child 6 month 4 year age : Willing participate study annually 5 year ( yes , consider annual return group ) . 5 . Acceptable medical history review inclusion/exclusion criterion vital sign . 6 . Influenza vaccinenaive one prior season flu immunization IIV ( apply Groups F G ) . 1 . Prior offstudy vaccination current year 's seasonal influenza vaccine 2 . Receipt LAIV prior season ( apply Groups F G ) 3 . Received flu immunization 2 prior flu season ( apply Groups F G ) 4 . Allergy egg egg product , vaccine component , ( include gentamicin , gelatin , arginine MSG give LAIV4 ) 5 . Lifethreatening reaction previous influenza vaccination 6 . Asthma adult . Children age 2 4 year asthma wheeze episode note medical record within past 12 month , parent report health care provider state wheeze asthma within last 12 month [ If yes , eligible LAIV Groups A , B , C , &amp; F ] . 7 . Active systemic serious concurrent illness , include febrile illness day vaccination 8 . History immunodeficiency ( include HIV infection ) 9 . For child adolescent 17 year age , receive aspirin therapy aspirincontaining product [ If yes , eligible LAIV Groups A , B , C , F ] . 10 . Known suspected impairment immunologic function , include , limited , clinically significant liver disease , diabetes mellitus treat insulin , moderate severe renal disease , chronic disorder , opinion investigator , might jeopardize volunteer safety compliance protocol . 11 . Blood pressure &gt; 150 systolic &gt; 95 diastolic first study visit day vaccination ( child 12 yr old , adult ) . 12 . Hospitalization past year congestive heart failure emphysema . 13 . Chronic Hepatitis B C 14 . Recent current use immunosuppressive medication , include systemic glucocorticoid ( corticosteroid nasal spray topical steroid permissible group ; inhale steroid use permissible ) 15 . Participants close contact anyone severely weaken immune system require protective environment . Exposure person avoid 7 day receipt LAIV . [ If yes , may ineligible Groups A , B , C F ] . 16 . Malignancy , squamous cell basal cell skin cancer ( include solid tumor breast cancer prostate cancer recurrence past year , hematologic cancer leukemia ) . 17 . Autoimmune disease ( include rheumatoid arthritis treat immunosuppressive medication Plaquenil , methotrexate , prednisone , Enbrel ) , opinion investigator , might jeopardize volunteer safety compliance protocol 18 . History blood dyscrasia , renal disease , hemoglobinopathies require regular medical follow hospitalization precede year 19 . Use anticoagulation medication Coumadin Lovenox , antiplatelet agent aspirin ( except 325 mg. per day ) , Plavix , Aggrenox must review investigator determine would affect volunteer 's safety . 20 . Has take influenza antiviral medication within 48 hour prior study vaccination [ If yes , eligible LAIV Groups A , B , C F ] . 21 . Receipt blood blood product within past 6 month plan use study 22 . Medical psychiatric condition occupational responsibility preclude participant compliance protocol . 23 . Receipt inactivate vaccine 14 day prior study enrollment , plan vaccination prior completion last study visit 24 . Receipt live , attenuated vaccine within 60 day prior enrollment plan vaccination prior completion last study visit 25 . Need allergy immunization ( postpone ) study period 26 . History GuillainBarre syndrome 27 . Pregnant woman 28 . Breastfeeding [ If yes , eligible LAIV Group F ] 29 . Use investigational agent within 30 day prior enrollment plan use study 30 . Donation equivalent unit blood within 6 week prior enrollment plan donation prior completion last visit 31 . Any condition , opinion investigator , might interfere volunteer safety , study objective ability participant understand comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inactivated influenza vaccine</keyword>
	<keyword>Live , attenuate influenza vaccine</keyword>
	<keyword>Young child</keyword>
	<keyword>Adults</keyword>
</DOC>